ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Dr Robert K Naviaux Joins The Open Medicine Foundation's ME/CFS Scientific Advisory Board
Thursday 11 February 2016
From the Open Medicine Foundation (via email):
OMF welcomes Dr. Robert K. Naviaux, newest Scientific Advisory Board member
We’ve captured the interest – and will now benefit from the experience, knowledge, and skills – of another esteemed scientific expert.
Dr. Robert K. Naviaux has joined our ME/CFS Scientific Advisory Board and is internationally known for his work in human genetics, metabolism, metabolomics, and mitochondrial disease.
Having Dr. Naviaux join our team fits the pattern we set last year: create a scientific advisory board of noted experts in the biology systems that could be contributing to ME/CFS symptoms. These well-known researchers and doctors bring with them their network of relationships with labs and other scientists–and their knowledge and prestige–so we can move the research from the fringe and shadows into an exciting and respected field. And most of all, get fast results.
Dr. Naviaux is an ideal scientist to add to our esteemed board because of his deep understanding in mitochondrial dysfunctions, virology, tumor immunology, and natural killer cell biology.
Dr. Naviaux runs the Robert Naviaux Laboratory at UC San Diego, which is doing genetic research into mitochondrial dysfunctions. He is founder and co-director of the Mitochondrial and Metabolic Disease Center at UCSD. Additionally, he is a former president of the Mitochondrial Medicine Society and a founding associate editor of the journal Mitochondrion. He studied biochemistry at Georg-August University in Göttingen, Germany.
Dr. Naviaux discovered the cause and created the diagnostic test for Alpers syndrome, a mitochondrial disease. He also works in oceanographic ecosystems research and is the director of the first FDA-approved clinical trial to study suramin as a treatment for autism.
WELCOME DR. NAVIAUX!
blog comments powered by Disqus